Acceleron Pharma Inc Revenu Q/Q
Quel est le Revenu Q/Q de Acceleron Pharma Inc?
Le Revenu Q/Q de Acceleron Pharma Inc est 51.58%
Quelle est la définition de Revenu Q/Q?
La croissance trimestrielle du chiffre d'affaires, d'une année sur l'autre , correspond à l'augmentation du chiffre d'affaires d'une entreprise par rapport à la performance du trimestre correspondant d'un exercice précédent, exprimée en pourcentage.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenu Q/Q des entreprises dans Health Care secteur sur NASDAQ par rapport à Acceleron Pharma Inc
Que fait Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Entreprises avec revenu q/q similaire à Acceleron Pharma Inc
- Skipper a Revenu Q/Q de 51.50%
- TCS PLC a Revenu Q/Q de 51.50%
- Hemisphere a Revenu Q/Q de 51.50%
- 1st a Revenu Q/Q de 51.52%
- Metro Mining a Revenu Q/Q de 51.52%
- Shanthi Gears a Revenu Q/Q de 51.53%
- Acceleron Pharma Inc a Revenu Q/Q de 51.58%
- Gujarat Fluorochemicals a Revenu Q/Q de 51.59%
- Star Equity a Revenu Q/Q de 51.61%
- Persistent Systems a Revenu Q/Q de 51.61%
- Starcore International Mines a Revenu Q/Q de 51.62%
- Bombardier a Revenu Q/Q de 51.62%
- Morses Club PLC a Revenu Q/Q de 51.64%